Antibodies to Plasmodium vivax PvDBP recognize VAR2CSA and block adhesion of P. falciparum-infected red cells to chondroitin sulphate A
Immunity, pathogenesis and vaccine discovery and development
Sedami Gnidehou 1
;
C. Mitran 2
;
E. Arango 3
;
S. Banman 2
;
A. Mena 2
;
E. Medawar 2
;
B. Lima 4
;
J. Rajwani 2
;
A. Jin 2
;
J. Doritchamou 5
;
K. Gavina 6
;
Francis B Ntunmgia
;
N. Ndam 7
;
A Salanti 8
;
Flora S Kano 4
;
L. H. Carvalho 4
;
J. H. Adams 9
;
A. Maestre 3
;
M.F. Good 10
;
S. K. Yanow 11
1 Campus Saint-Jean, University of Alberta, Edmonton, Alberta, Canada
;
2 School of Public Health, University of Alberta, Edmonton, Alberta, Canada
;
3 Universidad de Antioquia, Medellín, Colombia
;
4 FIOCRUZ, Belo Horizonte, Brazil
;
5 National Institute of Allergy and Infectious Diseases, NIH, Bethesda, USA
;
6 Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada
;
7 University of Ghana, Accra, Ghana
;
8 Department of Immunology and Microbiology,Centre for Medical Parasitology, University of Copenhagen, Copenhagen, Denmark
;
9 University of South Florida, Tampa, USA
;
10 Institute for Glycomics, Griffith University, Gold Coast, Queensland, Australia
;
11 School of Public Health, University of Alberta, Edmonton, Alberta, Canada and Department of Medical Microbiology and Immunology, University of Alberta, Edmonton, Alberta, Canada
Vol.1, 2017 -
63241